Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Megacap 300 Value Index ETF Vanguard | MGV | Sep 30, 2024 | 128.28 | +0.35 |
MEI Pharma | MEIP | Sep 30, 2024 | 2.85 | -1.72 |
Meihua International Medical Technologies | MHUA | Sep 30, 2024 | 1.02 | -1.92 |
MeiraGTx Holdings | MGTX | Sep 30, 2024 | 4.17 | -2.11 |
Meiwu Technology | WNW | Sep 30, 2024 | 0.86 | -1.37 |
Melar Acquisition I | MACI | Sep 30, 2024 | 9.99 | 0.00 |
Melar Acquisition I | MACIU | Sep 30, 2024 | 10.03 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Sep 30, 2024 | 7.79 | +1.17 |
MercadoLibre | MELI | Sep 30, 2024 | 2 051.96 | -0.62 |
Mercantile Bank | MBWM | Sep 30, 2024 | 43.72 | +2.73 |
Mercer International | MERC | Sep 30, 2024 | 6.77 | +2.11 |
Merchants Bancorp | MBIN | Sep 30, 2024 | 44.96 | +0.99 |
Merchants Bancorp B | MBINO | Sep 30, 2024 | 25.15 | +0.00 |
Merchants Bancorp C Pref | MBINN | Sep 30, 2024 | 23.95 | -0.13 |
Merchants Bancorp Pref D | MBINM | Sep 30, 2024 | 25.59 | -1.43 |
Merck & Co | MRK | Sep 30, 2024 | 113.56 | -0.11 |
Mercurity Fintech | MFH | Sep 30, 2024 | 1.74 | -0.46 |
Mercury General | MCY | Sep 30, 2024 | 62.98 | -0.40 |
Mercury Systems | MRCY | Sep 30, 2024 | 37.00 | -1.33 |
Mereo BioPharma ADR | MREO | Sep 30, 2024 | 4.11 | -0.72 |
Meridian | MRBK | Sep 30, 2024 | 12.64 | +0.24 |
MeridianLink | MLNK | Sep 30, 2024 | 20.57 | -2.00 |
Merit Medical Systems | MMSI | Sep 30, 2024 | 98.83 | +1.18 |
Meritage Homes | MTH | Sep 30, 2024 | 205.07 | +0.65 |
Merrill Lynch & Co. | IPB | Sep 30, 2024 | 26.74 | +0.15 |
Mersana Therapeutics | MRSN | Sep 30, 2024 | 1.89 | +2.16 |
Merus N.V | MRUS | Sep 30, 2024 | 49.96 | +4.65 |
Mesa Air Group | MESA | Sep 30, 2024 | 1.21 | +2.54 |
Mesa Laboratories | MLAB | Sep 30, 2024 | 129.86 | +1.68 |
Mesa Royalty Trust | MTR | Sep 30, 2024 | 5.67 | -1.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.